Dr. Todd holds a Ph.D. in Physics from The University of Birmingham in England. He is an Associate Professor in the Department of Community and Preventive Medicine at Mount Sinai School of Medicine and is also an Adjunct Associate Professor at the Johns Hopkins University, Bloomberg School of Public Health. He was formerly a Visiting Professor at The University of Maryland (Baltimore), Program in Toxicology.
Dr. Todd has been the Principal Investigator of several NIH-funded studies and a co-investigator of several others. His research work has centered on both the development of in vivo bone lead measurements for the assessment of long-term lead exposure and on the application of those techniques to studies of human health research; work that has resulted in approaching 160 peer-reviewed papers. Dr. Todd's current scientific work covers all aspects of in vivo bone measurements in both national and international arenas.
Dr. Todd has reviewed for the National Institutes of Health and the American Public Health Association, and for Environmental Research, Environmental Health Perspectives, JAMA (Journal of the American Medical Association), Medical Physics and Physics in Medicine and Biology. He is also a Contributing Editor to the American Journal of Industrial Medicine.
Education
PhD, University of Birmingham
Bone Lead Measurements
Dr. Todd is one of the country's leading experts for a novel technique for measuring long-term lead exposure. Currently, he measures people who are volunteer subjects for federally funded research studies but also measures many people who are referred to him by physicians and by lawyers because they have symptoms of lead toxicity or are concerned about lead exposure they may have suffered in the past. The information obtained from bone lead measurements can provide evidence of historical lead exposure, in the absence of documented exposure.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Todd did not report having any of the following types of financial relationships with industry during 2017 and/or 2018: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.